Abstract
Efforts to optimize ablative therapies rely on an understanding of the combinatorial effects of the biophysical events related to the “energy” component of the therapy and the molecular mechanisms of response that, together, impact stress levels on cancer cells and therefore efficacy. Cryoablation is long recognized for its destructive action based on biophysical parameters associated with ice intrusion on cellular and tissue structure. More recent evidence has revealed a complex set of molecular responses that provides a path for optimization using cryosensitizing agents. In this chapter, we identify those elements key to effective cryoablation and likely future approaches designed to optimize cancer cell mortality while reducing damage to nontargeted, adjacent tissues.
An erratum to this chapter is available at http:/dx.doi.org/10.1007/978-1-62703-182-0_29
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-1-62703-182-0_29
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cooper IS. Cryobiology as viewed by the surgeon. Cryobiology. 1964;51:44–51.
Cooper IS. Cryogenic surgery for cancer. Fed Proc. 1965;24:S237–40.
Kreyberg L. Tissue damage due to cold. Lancet. 1946;1:338–40.
Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;247:C125–42.
Muldrew K, McGann LE. The osmotic rupture hypothesis of intracellular freezing injury. Biophys J. 1994;66:532–41.
Mazur P. Physical-chemical factors underlying cell injury in cryosurgical freezing. In: Rand RP, Rinfret A, Von Leden H, editors. Cryosurgery. Springfield, IL: Charles C. Thomas; 1967. p. 32–51.
Toscano W, Cravalho E, Silvares O, Huggins C. The thermodynamics of intracellular ice nucleation in the freezing of erythrocytes. J Heat Transfer. 1975;97:326–32.
Rubinsky B, Lee CY, Bastacky J, Onik G. The process of freezing and the mechanism of damage during hepatic cryosurgery. Cryobiology. 1990;27:85–97.
Bischof J, Christov K, Rubinsky B. A morphological study of cooling rate response in normal and neoplastic human liver tissue: cryosurgical implications. Cryobiology. 1993;30:482–92.
Hong JS, Rubinsky B. Patterns of ice formation in normal and malignant breast tissue. Cryobiology. 1994;31:109–20.
Berger WK, Uhrik B. Freeze-induced shrinkage of individual cells and cell-to-cell propagation of intracellular ice in cell chains from salivary glands. Experientia. 1996;52:843–50.
Quintanilla R, Krusen FH, Essex HE. Studies on frost-bite with special reference to treatment and the effect on minute blood vessels. Am J Physiol. 1947;149:149–61.
Zacarian SA, Stone D, Clater M. Effects of cryogenic temperatures on microcirculation in the golden hamster cheek pouch. Cryobiology. 1970;7:27–39.
Adams-Ray J, Bellman S. Vascular reactions after experimental cold injury; a microangiographic study of rabbit ears. Angiology. 1956;7:339–67.
Bowers Jr WD, Hubbard RW, Daum RC, Ashbaugh P, Nilson E. Ultrastructural studies of muscle cells and vascular endothelium immediately after freeze-thaw injury. Cryobiology. 1973;10:9–21.
Giampapa VC, Oh C, Aufses Jr AH. The vascular effect of cold injury. Cryobiology. 1981;18:49–54.
Gill W, Da Costa J, Fraser J. The control and predictability of a cryolesion. Cryobiology. 1970;6:347–53.
LeFebvre JH, Folke LE. Effects of subzero temperatures on the microcirculation in the oral mucous membrane. Microvasc Res. 1975;10:360–72.
Lenz H. Cryosurgery of the cheek pouch of the golden Syrian hamster. Physical, vascular, macroscopic and histologic observations. Int Surg. 1972;57:223–8.
Ninomiya T, Yosimura H, Mori M. Identification of vascular system in experimental carcinoma for cryosurgery–histochemical observations of lectin UEA-1 and alkaline phosphatase activity in vascular endothelium. Cryobiology. 1985;22:331–5.
Rabb JM, Renaud ML, Brandt PA, Witt CW. Effect of freezing and thawing on the microcirculation and capillary endothelium of the hamster cheek pouch. Cryobiology. 1974;11:508–18.
Rothenborg HW. Cutaneous circulation in rabbits and humans before, during, and after cryosurgical procedures measured by xenon-133 clearance. Cryobiology. 1970;6:507–11.
Whittaker DK. Vascular responses in the oral mucosa following cryosurgery. J Periodontal Res. 1977;12:55–63.
Mundth E. Studies on the pathogenesis of cold injury: microcirculatory changes in tissue injured by freezing. Proc Symp Artic Biol Med. 1964;4:51–72.
Whittaker DK. Electron microscopy of the ice crystals formed during cryosurgery: relationship to duration of freeze. Cryobiology. 1978;15:603–7.
Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann R Coll Surg Engl. 1984;66:313–8.
Bourne MH, Piepkorn MW, Clayton F, Leonard LG. Analysis of microvascular changes in frostbite injury. J Surg Res. 1986;40:26–35.
Gage AA, Ishikawa H, Winter PM. Experimental frostbite and hyperbaric oxygenation. Surgery. 1969;66:1044–50.
Hoffman NE, Bischof JC. Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber: Part II – Injury response. Tissue ASME. 1981;123:310–6.
Le Pivert P. Basic considerations of the cryolesion. In: Ablin R, editor. Cryosurgery. New York: Dekkar; 1980. p. 15–68.
Bischof JC, Smith D, Pazhayannur PV, Manivel C, Hulbert J, Roberts KP. Cryosurgery of dunning AT-1 rat prostate tumor: thermal, biophysical, and viability response at the cellular and tissue level. Cryobiology. 1997;34:42–69.
Klossner DP, Baust JM, Van Buskirk RG, Gage AA, Baust JG. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression. BJU Int. 2008;101:1310–6.
Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol. 1966;3:372–8.
Soanes WA, Gonder MJ. Cryosurgery in benign and malignant diseases of the prostate. Int Surg. 1969;51:104–16.
Dow JA. Effects of surgical capsular temperature on cryosurgery of the prostate. J Urol. 1968;100:66–71.
Green NA. Cryosurgery of the prostate gland. Ann R Coll Surg Engl. 1977;59:288–97.
Gage AA, Huben RP. Cryosurgical ablation of the prostate. Urol Oncol. 2000;5:11–9.
Lenz H, Goertz G, Preussler H. The minimal freezing temperature for a necrosis of the epidermis and the influence of cryoprotective agents (author’s transl). Arch Otorhinolaryngol. 1975;209:217–21.
Schmidlin FR, Rupp CC, Hoffmann NE, et al. Measurement and prediction of thermal behavior and acute assessment of injury in a pig model of renal cryosurgery. J Endourol. 2001;15:193–7.
Rupp CC, Hoffmann NE, Schmidlin FR, Swanlund DJ, Bischof JC, Coad JE. Cryosurgical changes in the porcine kidney: histologic analysis with thermal history correlation. Cryobiology. 2002;45:167–82.
Gage AA. Experimental cryogenic injury of the palate: observations pertinent to cryosurgical destruction of tumors. Cryobiology. 1978;15:415–25.
Gage AA. What temperature is lethal for cells? J Dermatol Surg Oncol. 1979;5:459–60, 464.
Staren ED, Sabel MS, Gianakakis LM, et al. Cryosurgery of breast cancer. Arch Surg. 1997;132:28–33; discussion 34.
Yamada S, Tsubouchi S. Rapid cell death and cell population recovery in mouse skin epidermis after freezing. Cryobiology. 1976;13:317–27.
El-Shakhs SA, Shimi SA, Cuschieri A. Effective hepatic cryoablation: does it enhance tumor dissemination? World J Surg. 1999;23:306–10.
Neel 3rd HB, Ketcham AS, Hammond WG. Requisites for successful cryogenic surgery of cancer. Arch Surg. 1971;102:45–8.
Heard BE. Nuclear crystals in slowly frozen tissues at very low temperatures; comparison of normal and ascites tumour cells. Br J Surg. 1955;42:659–63.
Zacarian SA. The observation of freeze-thaw cycles upon cancer-cell suspensions. J Dermatol Surg Oncol. 1977;3:173–4.
Jacob G, Kurzer MN, Fuller BJ. An assessment of tumor cell viability after in vitro freezing. Cryobiology. 1985;22:417–26.
Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48:441–7.
Rubinsky B. The freezing process and mechanism of tissue damage. In: Onik G, Rubinsky B, Watson G, Ablin R, editors. Percutaneous prostate cryoablation. St. Louis: Quality Medical Publishing; 1995. p. 46–68.
Burge SM, Shepherd JP, Dawber RP. Effect of freezing the helix and the rim or edge of the human and pig ear. J Dermatol Surg Oncol. 1984;10:816–9.
Gage AA, Guest K, Montes M, Caruana JA, Whalen Jr DA. Effect of varying freezing and thawing rates in experimental cryosurgery. Cryobiology. 1985;22:175–82.
Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60:40–9.
Neel 3rd HB, DeSanto LW. Cryosurgical control of cancer: effects of freeze rates, tumor temperatures, and ischemia. Ann Otol Rhinol Laryngol. 1973;82:716–23.
Mazur P. The role of intracellular freezing in the death of cells cooled at supraoptimal rates. Cryobiology. 1977;14:251–72.
Cahan WG. Cryosurgery of malignant and benign tumors. Fed Proc. 1965;24:S241–8.
Gage AA, Koepf S, Wehrle D, Emmings F. Cryotherapy for cancer of the lip and oral cavity. Cancer. 1965;18:1646–51.
Gill W, Fraser J, Carter DC. Repeated freeze-thaw cycles in cryosurgery. Nature. 1968;219:410–3.
Whittaker DK. Repeat freeze cycles in cryosurgery of oral tissues. Br Dent J. 1975;139:459–65.
Gage AA, Augustynowicz S, Montes M, Caruana JA, Whalen Jr DA. Tissue impedance and temperature measurements in relation to necrosis in experimental cryosurgery. Cryobiology. 1985;22:282–8.
Dilley AV, Dy DY, Warlters A, et al. Laboratory and animal model evaluation of the Cryotech LCS 2000 in hepatic cryotherapy. Cryobiology. 1993;30:74–85.
Gage AA, Caruana Jr JA, Montes M. Critical temperature for skin necrosis in experimental cryosurgery. Cryobiology. 1982;19:273–82.
Mala T, Edwin B, Tillung T, Kristian Hol P, Soreide O, Gladhaug I. Percutaneous cryoablation of colorectal liver metastases: potentiated by two consecutive freeze-thaw cycles. Cryobiology. 2003;46:99–102.
Myers R, Hammond WG, Ketcham AS. Cryosurgery of experimental tumors. J Cryosurg. 1969;2:225–8.
Neel 3rd HB, Ketcham AS, Hammond WG. Cryonecrosis of normal and tumor-bearing rat liver potentiated by inflow occlusion. Cancer. 1971;28:1211–8.
Rand RW, Rand RP, Eggerding F, DenBesten L, King W. Cryolumpectomy for carcinoma of the breast. Surg Gynecol Obstet. 1987;165:392–6.
Ravikumar TS, Steele Jr G, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 1991;51:6323–7.
Woolley ML, Schulsinger DA, Durand DB, Zeltser IS, Waltzer WC. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol. 2002;16:519–22.
Saliken JC, Cohen J, Miller R, Rothert M. Laboratory evaluation of ice formation around a 3-mm Accuprobe. Cryobiology. 1995;32:285–95.
Pogrel MA, Yen CK, Taylor R. A study of infrared thermographic assessment of liquid nitrogen cryotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:396–401.
Hollister WR, Mathew AJ, Baust JG, Van Buskirk RG. Effects of freezing on cell viability and mechanisms of cell death in a human prostate cell line. Mol Urol. 1998;2:13–8.
Hanai A, Yang WL, Ravikumar TS. Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: mediation by cytochrome c release. Int J Cancer. 2001;93:526–33.
Yang WL, Addona T, Nair DG, Qi L, Ravikumar TS. Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer. 2003;103:360–9.
Steinbach JP, Weissenberger J, Aguzzi A. Distinct phases of cryogenic tissue damage in the cerebral cortex of wild-type and c-fos deficient mice. Neuropathol Appl Neurobiol. 1999;25:468–80.
Wang H, Tu HJ, Qin J, et al. Effect of cryotherapy and 5-fluorouracil on apoptosis of G422 glioma cells. Ai Zheng. 2004;23:412–5.
Forest V, Peoch’m M, Campos L, Guyotat D, Vergnon JM. Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Cryobiology. 2005;50:29–37.
Baust JG, Gage AA, Clarke D, Baust JM, Van Buskirk R. Cryosurgery–a putative approach to molecular-based optimization. Cryobiology. 2004;48:190–204.
Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci. 2007;32:37–43.
Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010;22:263–8.
Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res. 2003;283:1–16.
Kinnally KW, Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis. 2007;12:857–68.
Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology. 2004;49:45–61.
Robilotto AT, Clarke D, Baust JM, Van Buskirk RG, Gage AA, Baust JG. Development of a tissue engineered human prostate tumor equivalent for use in the evaluation of cryoablative techniques. Technol Cancer Res Treat. 2007;6:81–9.
Clarke DM, Robilotto AT, Van Buskirk RG, Baust JG, Gage AA, Baust JM. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2007;10:175–84.
Jiang J, Goel R, Schmechel S, Vercellotti G, Forster C, Bischof J. Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-alpha enhanced cryotherapy in an in vivo prostate cancer model system. Cryobiology. 2010;61:280–8.
Ponder E. The coefficient of thermal conductivity of blood and of various tissues. J Gen Physiol. 1962;45:545–51.
Babaian RJ, Donnelly B, Bahn D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180:1993–2004.
Benson JW. Regional chemotherapy and local cryotherapy for cancer. Oncology. 1972;26:134–51.
Ikekawa S, Ishihara K, Tanaka S, Ikeda S. Basic studies of cryochemotherapy in a murine tumor system. Cryobiology. 1985;22:477–83.
Homasson JP, Pecking A, Roden S, Angebault M, Bonniot JP. Tumor fixation of bleomycin labeled with 57 cobalt before and after cryotherapy of bronchial carcinoma. Cryobiology. 1992;29:543–8.
Mir LM, Rubinsky B. Treatment of cancer with cryochemotherapy. Br J Cancer. 2002;86:1658–60.
Saika T, Satoh T, Kusaka N, et al. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model. Cancer Gene Ther. 2004;11:317–24.
Le Pivert P, Haddad RS, Aller A, et al. Ultrasound guided combined cryoablation and microencapsulated 5-Fluorouracil inhibits growth of human prostate tumors in xenogenic mouse model assessed by luminescence imaging. Technol Cancer Res Treat. 2004;3:135–42.
Burton SA, Paljug WR, Kalnicki S, Werts ED. Hypothermia-enhanced human tumor cell radiosensitivity. Cryobiology. 1997;35:70–8.
Znati C, Werts E, Kociban D, Kalnicki S. Variables influencing response of human prostate carcinoma cells to combined radiation and cryotherapy in vitro. Cryobiology. 1998;37:376–452.
Koushafar H, Rubinsky B. Effect of antifreeze proteins on frozen primary prostatic adenocarcinoma cells. Urology. 1997;49:421–5.
Pham L, Dahiya R, Rubinsky B. An in vivo study of antifreeze protein adjuvant cryosurgery. Cryobiology. 1999;38:169–75.
Muldrew K, Rewcastle J, Donnelly BJ, et al. Flounder antifreeze peptides increase the efficacy of cryosurgery. Cryobiology. 2001;42:182–9.
Clarke DM, Hollister WR, Baust JG, Van Buskirk RG. Cryosurgical modeling: sequence of freezing and cytotoxic agent application affects cell death. Mol Urol. 1999;3:25–31.
Watanabe N, Niitsu Y, Umeno H, et al. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 1988;48:2179–83.
Chao BH, He X, Bischof JC. Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer. Cryobiology. 2004;49:10–27.
Hegeman RB, Liu G, Wilding G, McNeel DG. Newer therapies in advanced prostate cancer. Clin Prostate Cancer. 2004;3:150–6.
Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology. 2001;42:274–85.
Santucci KL, Snyder KK, Baust JM, et al. Use of 1,25alpha dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model. Prostate Cancer Prostatic Dis. 2011;14:97–104.
Baust JM, Klossner DP, Robilotto A, et al. Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis. BJU Int. 2012;109(6):949–58.
Shulman S, Yantorno C, Bronson P. Cryo-immunology: a method of immunization to autologous tissue. Proc Soc Exp Biol Med. 1967;124:658–61.
Blackwood CE, Cooper IS. Response of experimental tumor systems to cryosurgery. Cryobiology. 1972;9:508–15.
Joosten JJ, Muijen GN, Wobbes T, Ruers TJ. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology. 2001;42:49–58.
Joosten JJ, van Muijen GN, Wobbes T, Ruers TJ. Cryosurgery of tumor tissue causes endotoxin tolerance through an inflammatory response. Anticancer Res. 2003;23:427–32.
Hoffmann NE, Coad JE, Huot CS, Swanlund DJ, Bischof JC. Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat. Cryobiology. 2001;42:59–68.
Shibata T, Suzuki K, Yamashita T, et al. Immunological analysis of enhanced spontaneous metastasis in WKA rats following cryosurgery. Anticancer Res. 1998;18:2483–6.
Slovin SF, Kelly WK, Scher HI. Immunological approaches for the treatment of prostate cancer. Semin Urol Oncol. 1998;16:53–9.
Bremers AJ, Kuppen PJ, Parmiani G. Tumour immunotherapy: the adjuvant treatment of the 21st century? Eur J Surg Oncol. 2000;26:418–24.
Urano M, Tanaka C, Sugiyama Y, Miya K, Saji S. Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model. Cryobiology. 2003;46:238–45.
Steinman RM. Some interfaces of dendritic cell biology. APMIS. 2003;111:675–97.
Small EJ, Sacks N, Nemunaitis J, et al. Granulocyte macrophage colony-stimulating factor–secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer. Clin Cancer Res. 2007;13:3883–91.
Simons JW, Sacks N. Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer. Urol Oncol. 2006;24:419–24.
Nanus DM, Milowsky MI, Kostakoglu L, et al. Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. J Urol. 2003;170:S84–8; discussion S88–9.
Yamashita T, Hayakawa K, Hosokawa M, et al. Enhanced tumor metastases in rats following cryosurgery of primary tumor. Jpn J Cancer Res. 1982;73:222–8.
Seifert JK, France MP, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg. 2002;26:1333–41.
Fushimi N, Jinno H, Washida H, Ueda K, Otaguro K. Humoral immunity following double-freezing of the prostate in patients with prostatic cancer. Cryobiology. 1982;19:242–6.
Chapman WC, Debelak JP, Blackwell TS, et al. Hepatic cryoablation-induced acute lung injury: pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg. 2000;135:667–72; discussion 672–3.
Wudel Jr LJ, Allos TM, Washington MK, Sheller JR, Chapman WC. Multi-organ inflammation after hepatic cryoablation in BALB/c mice. J Surg Res. 2003;112:131–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Baust, J.M., Santucci, K., Gage, A.A., Robilotto, A. (2013). Optimizing Ablative Therapy: Manipulating the Microenvironment. In: Polascik, T. (eds) Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-182-0_26
Download citation
DOI: https://doi.org/10.1007/978-1-62703-182-0_26
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-181-3
Online ISBN: 978-1-62703-182-0
eBook Packages: MedicineMedicine (R0)